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Lipids be gone
P
hosphoinositides (PIs) get the boot on page 377. Using a new method 
to eliminate PI(4,5)P2 from the plasma membrane, Varnai et al. create 
problems for receptor endocytosis and ion channels.
Until now, changing cellular PI levels in vivo meant playing the waiting 
game: express a kinase or phosphatase to make or eliminate a lipid species, and 
then wait half a day for the change to take place. During this lag, the gradual, 
persistent lipid modiﬁ  cations initiate trafﬁ  cking and signaling events that distort 
the more immediate effect on any particular function.
Varnai and colleagues have now devised a quicker way to drop lipid 
levels. They hooked a drug-inducible plasma membrane targeting domain to a 
phosphatase that hydrolyzes PIP2. Add the drug, and voila: comparatively instant 
gratiﬁ  cation that takes minutes at most.
The group used their method to prove a pair of suspected functions for PIP2. First, 
its loss from the plasma membrane blocked the internalization of growth factor recep-
tors, presumably because the lipid is needed to recruit endocytic adaptor proteins.
Loss of PIP2 also prevented IP3-induced calcium waves and blocked acti-
vation of a cold-responsive ion channel. Whether the lipid is simply permissive 
for channel opening or regulates channel activity, perhaps by inducing confor-
mational changes, is unresolved.
Having touched on the plasma membrane, the group now plans to tackle 
other cellular compartments and lipids. They are targeting the phosphatase to 
the Golgi, ER, and mitochondria, and looking into PI4P function, particularly 
during membrane trafﬁ  cking.
Each new circumstance requires its own ﬁ  ne tuning, of course. Kinases and phosphatases might 
have their own targeting signals that must ﬁ  rst be destroyed, and even cytoplasmic versions at high 
enough concentrations can change membrane lipid levels, the authors discovered. Yet their enthusiasm 
remains high, particularly as they get more and more PI levels to drop.
eIF4E exports proliferation mRNAs
C
ells experiencing a nutrient boon 
take advantage by ramping up 
translation. One of the translation-
boosting factors keeps the good times rolling 
by moonlighting as an mRNA export factor. 
On page 415, Culjkovic et al. now show that 
eIF4E sends a slew of proliferation-inducing 
transcripts into the cytoplasm, possibly for 
priority translation.
The moonlighting is nothing new for 
this translation initiation factor—boosting 
eIF4E was known to increase the nuclear 
export of transcripts for cyclin D1 and 
ornithine decarboxylase. But the authors 
now fi   nd that eIF4E has many nuclear 
targets, most of which encode proteins 
that promote survival and cell division. 
High levels of eIF4E increased the export 
of these messages and, consequently, 
levels of their proteins.
In the cytoplasm, eIF4E binds to the 
m7G that caps all mRNAs. But in the nu-
cleus, eIF4E, together with as-yet unknown 
factors, recognize a structural element—a 
complex pair of stem loops—within the 
3′ UTRs of its specifi  c export targets.
Transcripts containing this element 
formed nuclear foci with eIF4E and its 
associated proteins. The multifunctional 
PML growth inhibitor binds to nuclear 
eIF4E and prevents transcripts from 
getting hold. PML is induced by genomic 
damage and other stresses—conditions in 
which proliferation is unwanted and 
potentially dangerous.
The eIF4E-dependent pathway is sepa-
rate from bulk export that relies on NXF1, 
as it instead depends on the CRM1 export 
receptor. This separation might open up a 
VIP pathway to the cytoplasm for eIF4E-
associated transcripts, giving them a head 
start on translation in response to growth 
factors and other extracellular conditions 
that call for proliferation.
Many cancer cells contain high levels 
of eIF4E, which is a promising target for 
small molecule inhibitors. Reducing 
eIF4E activity should curtail the export 
and translation of an entire network of 
proliferation-inducing transcripts.
Internalization of transferrin (green)-bound receptor 
is blocked in cells lacking plasma membrane 
PIP2 (red cells).
eIF4E (green) exports transcripts with a 
particular stem loop structure (red), but 
PML (blue) interferes with their interaction.